Clinical Trial Update: Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People [Phase 2, Phase 3]

View source ↗

Summary

An investigational vaccine designed to prevent disseminated tuberculosis in people with HIV has completed Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Investigational vaccine for the prevention of disseminated tuberculosis in HIV-infected people

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Tuberculosis, HIV Infections | Phase 2, Phase 3 | Status: COMPLETED